If you have trouble viewing this newsletter click here

April 2011

 In this issue:


 FDA Import Entry Review Process

When an imported product arrives in the US, certain information must be provided/transmitted electronically to the United States Customs and Border Protection (CBP).   When the product is or may be regulated by FDA, CBP sends the import entry information to FDA for verification to ensure that the product meets FDA requirements. Without the proper information, FDA may initiate a manual review of each line of your entry, which may lead to delays in its release to the importer/consignee.

FDA recently issued a letter to device companies regarding concerns with some device types such as eyeglasses and electrode leads, that in their experience often do not have sufficient entry data for CBP.  Even if you do not produce these particular products for the US market, it is important to be aware of the US entry process to avoid delays.  If we are your United States Agent, don't worry - we will provide you with all the necessary information to include on your invoice for your shipment.  Let us know if you have any questions.

To access the full letter from FDA, click here.

Back to Top 


MDRA, Inc. now accepts major credit cards (MasterCard, Visa, Discover & American Express).  Contact us for details!

Contact us by email:  info@deviceadvice.com or by telephone: +1 (303) 463-0900

To Unsubscribe from this list, click here

Back to Top


 

 ©2010 All Rights Reserved. MDRA does not warranty the accuracy or suitability of this email for any purpose.
MDRA and deviceadvice.com are registered trademarks of Medical Device Regulatory Advisors, Inc.
Registered Address: 13605 West 7th Avenue, Golden, CO 80401 USA